课题基金 / 基金详情

项目摘要

项目成果

LIONEL David LEWIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since January 1996, a scientific review committee (Clinical Cancer Research Committee¿CCRC) and a Safety and Data Monitoring Committee (SDMC) have functioned at Norris Cotton Cancer Center. The CCRC reviews each new clinical trial protocol prior to Institutional Review Board (IRB) review, and the SDMC monitors safety and data integrity on a regular basis throughout the trial. Prior to IRB review, the NCCC Office of Clinical Research (OCR) submits the protocol to the CCRC. The CCRC is responsible for the scientific review of all new studies involving cancer patients or cancer prevention in human subjects. This assessment involves a review of all scientific aspects of the study, including the required safety and data monitoring plan. Once a protocol receives CCRC and IRB approval, the protocol is considered open for activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
  • 批准号:
    10761171
  • 项目类别:
  • 资助金额:
    $99.92万
  • 财政年份:
    2023
  • 负责人:
    LIONEL David LEWIS
  • 依托单位:
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
  • 批准号:
    10261525
  • 项目类别:
  • 资助金额:
    $101.56万
  • 财政年份:
    2020
  • 负责人:
    LIONEL David LEWIS
  • 依托单位:
Toxicology, Pathology and Biodistribution Core (TPB Core)
  • 批准号:
    7982610
  • 项目类别:
  • 资助金额:
    $9.59万
  • 财政年份:
    2010
  • 负责人:
    LIONEL David LEWIS
  • 依托单位:
CLINICAL PHARMACOLOGY SHARED RESOURCE
  • 批准号:
    7944619
  • 项目类别:
  • 资助金额:
    $15.14万
  • 财政年份:
    2009
  • 负责人:
    LIONEL David LEWIS
  • 依托单位:
海外基金